GenMont Biotech Incorporation (TPE:3164)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.05
+0.05 (0.28%)
Jan 22, 2026, 11:39 AM CST
-6.72%
Market Cap1.55B
Revenue (ttm)391.48M
Net Income (ttm)34.49M
Shares Out86.01M
EPS (ttm)0.39
PE Ratio46.16
Forward PEn/a
Dividend0.80 (4.44%)
Ex-Dividend DateMar 27, 2025
Volume18,742
Average Volume62,263
Open18.05
Previous Close18.00
Day's Range18.00 - 18.15
52-Week Range17.20 - 23.35
Beta0.21
RSI40.24
Earnings DateMar 13, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan. It offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. The company was founded in 2000 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3164
Full Company Profile

Financial Performance

In 2024, TPE:3164's revenue was 385.37 million, an increase of 21.18% compared to the previous year's 318.02 million. Earnings were 57.25 million, an increase of 73.54%.

Financial Statements